## Abstract This study reports in vivo and in vitro magnetic resonance spectroscopic findings in two cases of central neurocytomas (CNC) confirmed by immunohistochemistry. Volume localized in vivo proton magnetic resonance spectroscopy (MRS) was carried out before surgery using a point resolved spe
MRS characterization of central neurocytomas using glycine
โ Scribed by Tariq Shah; Rama Jayasundar; Virendera Paul Singh; Chitra Sarkar
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 373 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0952-3480
- DOI
- 10.1002/nbm.1705
No coin nor oath required. For personal study only.
โฆ Synopsis
This study reports in vivo MRS findings in 11 patients with histologically diagnosed central neurocytomas, which are rare intraventricular tumors of neuronal origin. Singleโvoxel ^1^H MRS was carried out prior to surgery using a pointโresolved spectroscopy sequence with TRโ=โ6โs, TEโ=โ135โms and 128 scans. In vitro highโresolution ^1^H spectroscopy was also carried out on two surgically excised samples. The striking features of the spectra from the central neurocytomas were the presence of high glycine, decreased Nโacetylaspartate, increased choline and alanine. Retrospective, blind analysis of the spectra by two independent observers correctly identified all but one central neurocytoma based on the presence of glycine. The presence of glycine and prominent choline in the ^1^H MR spectrum is a characteristic feature of the central neurocytomas, and could be used to characterize and differentiate them from other brain tumors. Copyright ยฉ 2011 John Wiley & Sons, Ltd.
๐ SIMILAR VOLUMES
## Abstract ## Purpose To determine the value of multivoxel proton magnetic resonance spectroscopic imaging (MRSI) in distinguishing malignant skeletal tumors from benign tumors and normal bone marrow using the metabolite choline (Cho) as a marker for malignancy. ## Materials and Methods Patholo